BD News Archive

2015

August

Media Release / Aug 27, 2015

Read More
Media Release / Aug 27, 2015

Novartis International BioCamp highlights how collaboration and diversity drive innovation and inspires future science leaders

Read More
Media Release / Aug 24, 2015

FDA expands use of Novartis drug Promacta® to include treatment of children ages 1 and older with chronic immune thrombocytopenia

Read More
Media Release / Aug 21, 2015

Novartis acquires all remaining rights to GSK's Ofatumumab to develop treatments for MS and other autoimmune indications

Read More
Media Release / Aug 20, 2015

Novartis drug Odomzo® gains EU approval for locally advanced basal cell carcinoma, providing new non-invasive therapy for patients

Read More
Media Release / Aug 03, 2015

Novartis completes divestiture of influenza vaccines business to CSL Limited for USD 275 million

Read More

July

Media Release / Jul 29, 2015

Novartis partners with Phase 4 Partners and institutional investors to help create Mereo BioPharma Group Ltd

Read More
Media Release / Jul 27, 2015

Novartis Foundation confirms new members of its Board of trustees, including new Chairman Dr. Joerg Reinhardt

Read More
Media Release / Jul 24, 2015

FDA approves Novartis drug Odomzo® (sonidegib) for locally advanced basal cell carcinoma (laBCC), a form of skin cancer

Read More
Media Release / Jul 24, 2015

Novartis combination therapy Tafinlar® and Mekinist® achieves important EU and US regulatory milestones

Read More